![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study
GANEA2 study was designed to assess accuracy and safety of sentinel lymph node (SLN) after neo-adjuvant chemotherapy (NAC) in breast cancer patients.
-
Article
Prognostic value of metabolic parameters and clinical impact of 18F-fluorocholine PET/CT in biochemical recurrent prostate cancer
To evaluate the therapeutic impact of 18F-fluorocholine (FCH) PET/CT in biochemical recurrent prostate cancer (PC) and to investigate the value of quantitative FCH PET/CT parameters in predicting progression-free...
-
Article
Open AccessEvaluation in usual practice of the bevacizumab-FOLFIRI combination for the first-line treatment of patients with unresectable metastatic colorectal cancer treated in 2006: focus on resected patients and oncogeriatrics
En 2006, bevacizumab-FOLFIRI représente la thérapie ciblée administrable dès la première ligne chez les patients porteurs d’un cancer colorectal métastatique non opérable. Une série homogène de 111 patients co...
-
Chapter and Conference Paper
Qualité de vie après lipomodelage : étude rétrospective à propos de 42 patientes
Étude de la qualité de vie de 42 patientes ayant bénéficié d’un lipomodelage dans notre institut entre 2009 et 2010.
-
Chapter and Conference Paper
Le cancer du sein chez l’homme Approche épidémiologique, diagnostique et thérapeutique : étude multicentrique rétrospective à propos de 95 cas
Analyser les caractéristiques cliniques, histologiques et thérapeutiques de 95 hommes pris en charge pour un cancer du sein entre 2000 et 2010 dans 4 centres hospitaliers et déterminer des facteurs prédictifs ...
-
Article
Cytogenetic and therapeutic characterization of primary plasma cell leukemia: the IFM experience
-
Article
Open AccessValidation of UBE2C protein as a prognostic marker in node-positive breast cancer
We recently identified and validated UBE2C RNA as a prognostic marker in 252 node-positive (N+) breast cancers by means of a microarray study. The aim of this study was to validate UBE2C protein as a prognostic m...
-
Article
Open AccessPrognostic impact of syndecan-1 expression in invasive ductal breast carcinomas
Carcinoma cells lack syndecan-1 expression when they are transiting from an epithelial to a less-differentiated mesenchymal phenotype (epithelial–mesenchymal transition, EMT). Furthermore, a shift of syndecan-...
-
Article
Brown fat in breast cancer patients: analysis of serial 18F-FDG PET/CT scans
It has recently been suggested that FDG accumulation in the brown adipose tissue varies as a function of age, sex and outdoor temperature. The aim of this study was to assess changes in FDG uptake in brown fat...
-
Article
Open AccessG388R mutation of the FGFR4 gene is not relevant to breast cancer prognosis
This study screened large cohorts of node-positive and node-negative breast cancer patients to determine whether the G388R mutation of the FGFR4 gene is a useful prognostic marker for breast cancer as reported by...